B of A Securities Maintains Buy on HealthEquity, Lowers Price Target to $100
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Allen Lutz maintains a Buy rating on HealthEquity (NASDAQ:HQY) but lowers the price target from $105 to $100.
September 04, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
B of A Securities maintains a Buy rating on HealthEquity but reduces the price target from $105 to $100, indicating a slightly less optimistic outlook.
The maintenance of a Buy rating suggests continued confidence in HealthEquity's performance, but the lowered price target indicates a slightly reduced expectation for future gains. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100